Tag

CeraVe Archives - JDDonline - Journal of Drugs in Dermatology

Watch On Demand: Proper Hydration and Exfoliation Support Treatments for Patients with Inflammatory Skin Conditions

By JDD Webinars No Comments

JDD Multimedia

JDD Webinars

Watch On Demand

This exclusive #SkinChat webinar originally aired on December 16th, 2020. Dr. Leon H. Kircik and Professor Petra Staubach-Renz  discussed the importance of adjunctive skincare solutions for your patients with Keratosis Pilaris and Psoriasis.

Proper hydration and exfoliation support treatments for patients with inflammatory skin conditions

By Heather Onorati

People with conditions characterized by an impaired skin barrier and hyperkeratosis can benefit from incorporating a uniquely formulated skincare regimen with other recommended treatments, according to two experts who shared insights into how a variety of ingredients work to complement therapeutic selections and improve outcomes for these patients. 

In a recent webinar, Professor Petra Staubach-Renz, department of dermatology, University Medical Center, Mainz, Germany, and Leon H. Kircik, M.D., Icahn School of Medicine at Mount Sinai, New York, delivered very relevant presentations on adjunctive skincare solutions for hyperkeratolytic conditions.

Dry, rough, uneven skin is a common symptom for many of these hyperkeratolytic conditions, according to Prof. Staubach-Renz. This is characterized by a build-up of cells on the skin’s surface that create an irregular, thick texture. Hyperkeratosis commonly presents in patients with conditions like keratosis pilaris, ichythyosis, psoriasis, and atopic dermatitis.  

More than 40% of people around the world suffer from keratosis pilaris, also called follicular keratosis, Prof. Staubach-Renz noted. In addition, there are more than 125 million people globally who suffer from psoriasis, 60% of which report that the disease significantly affects their lives, Dr. Kircik added. The biggest problems that those affected report are the appearance of the skin and the scaling, which result from transepidermal water loss and a dysfunctional epidermal barrier, he explained. 

Dry, rough, uneven skin is a common symptom for many of these hyperkeratolytic conditions, according to Prof. Staubach-Renz. This is characterized by a build-up of cells on the skin’s surface that create an irregular, thick texture. Hyperkeratois commonly presents in patients with conditions like keratosis pilaris, ichythyosis, psoriasis, and atopic dermatitis.  

According to Prof. Staubach-Renz, this is important to understand in order to treat the skin with the proper basic therapy. There are several critical components, and those include mild exfoliation with keratolytics and an occlusive moisturizer. 

Keratolytics break down the outer layers of the skin, which ultimately allow for other topical therapeutics like corticosteroids to penetrate, Dr. Kircik explained. Often, people who are prescribed topical corticosteroid treatments will complain they are unsatisfied and that the treatment is not working. 

“This is where the keratolytics come into the picture, Dr. Kircik said. Compounds like urea and salicylic acid break down that thick skin and allow the topical medication to penetrate. 

Pairing this activity with humectants and an occlusive will support repair of the epidermal barrier by allowing the skin to attract and then retain moisture.  

One over-the-counter skincare system that utilizes this combination of ingredients in a unique timed-release delivery system demonstrated both efficacy and tolerability in two studies cited by Prof. Staubach-Renz, which examined their use in the treatment of keratosis pilaris. 

Researchers found in one study that patients experienced a decrease in transepidermal water loss 1 hour following use of both a cleanser and cream, cell turnover time accelerated at 3-5 days, and 9 of 10 patients subjectively agreed that the skin felt softer, smoother and more comfortable after week 4. In a second study, the severity of dryness, texture and erythema began to improve at two weeks on dermatologic exam. At 8 weeks, skin dryness was reduced by 76%, and there was a visual improvement in roughness and erythema.

 

 

 

 

Heather Onorati is an experienced medical writer and editor with more than 20 years covering the dermatology industry.

 

 

 

 

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

Adjunctive Skincare Solutions for Hyperkeratotic Skin Conditions, Including Keratosis Pilaris and Psoriasis

By JDD Webinars No Comments

JDD Multimedia

JDD Webinars

This #SkinChat orignally aired on December 16th, 2020. Tune in as Dr. Leon H. Kircik and Professor Petra Staubach-Renz discuss the importance of adjunctive skincare solutions for your patients with Keratosis Pilaris and Psoriasis.

Supported By

CeraVe #SkinChat

 

Adjunctive Skincare Solutions for Hyperkeratotic Skin Conditions, Including Keratosis Pilaris and Psoriasis

Featuring Leon Kircik, MD & Prof. Petra Staubach-Renz

Watch On Demand

Join the JDD & CeraVe for this exclusive, on-demand #SkinChat webcast, where Dr. Leon H. Kircik and Professor Petra Staubach-Renz discuss the importance of adjunctive skincare solutions for your patients with Keratosis Pilaris and Psoriasis.

This presentation  also includes relevant clinical data supporting the need for ceramides and skin barrier restoration regarding these Keratolytic skin conditions.

Faculty

Leon Kircik, MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York, NY
Indiana University Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville, KY

Prof. Petra Staubach-Renz
Senior Physician Dermatology and Allergy
Managing Director, Clinical Research Centre,
Department of Dermatology, University Medical Center
Mainz, Germany
Watch on Vimeo

You May Also Like

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

New Developments in Tetracycline-Class Antibiotics

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Christopher Bunick & Dr. Adam Friedman   Tetracycline antibiotics are like the Snickers of dermatology. Instead of "Hungry? Grab a Snickers," "Acne? Grab a…

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam…

View on Demand: Restoring Skin Barrier Function – Why Formulation Matters

By COVID-19 Webinars, JDD Webinars, Skin Barrier Function No Comments

JDD Multimedia

Webinar Premiere

“Restoring Skin Barrier Function: Why Formulation Matters"

With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin.

Tune in as Professor Michael J. Cork BSC MB PhD FRCP and Professor Simon G. Danby discuss the skin-barrier restoring effect of a cream containing ceramides in a multi-vesicular emulsion for people with eczema-prone skin, as well as other skin conditions that require skin-barrier restoration.

Faculty


Professor Michael J. Cork

BSC MB PhD FRCP

Joined the University of Sheffield in 1991 as a lecturer in dermatology whilst continuing as a practising dermatologist for the NHS in Sheffield. Previously, a Registrar in Dermatology at the Royal Hallamshire Hospital, Sheffield, and a Registrar in Respiratory General Medicine at Leeds General Infirmary.

Professor Cork has been closely involved with research in many areas of dermatology; including Atopic Eczema(dermatitis), Psoriasis, Vitiligo and the Genetics of Skin Disease. Major current research work is aimed at identifying gene–environment interactions in the development of atopic dermatitis leading to skin barrier breakdown and the understanding of how topical agents interact with the skin barrier; using this information to enhance the treatment of atopic dermatitis.

Currently the Head of Sheffield Dermatology Research in the Department of Infection, Immunity & Cardiovascular Disease at the University of Sheffield Medical School and Honorary Consultant Dermatologist to both Sheffield Children´s Hospital NHS Foundation Trust and to Sheffield Teaching Hospitals NHS Foundation Trust.

 


Professor Simon G. Danby
PhD, BSC

Originally trained in biochemistry and molecular biology, Professor Danby  joined the University of Sheffield in 2005 as a post-doctoral scientist in the Academic Unit of Biomedical Genetics.

In this position, he worked exclusively for York Pharma on the early stage development of novel therapeutics and diagnostics for atopic dermatitis, psoriasis and malignant melanoma.

In 2009, he joined the Academic Unit of Dermatology Research as a post-doctoral Research Associate. The focus of his research in this role was improving our understanding of the structure and function of the epidermal (skin) barrier and its role in the development of disorders such as atopic dermatitis (AD).

At the beginning of 2012, Professor Danby  was awarded a 3-year unencumbered research fellowship from Johnson & Johnson to continue my research on the skin barrier and set up a dedicated research facility for conducting human skin research.

Since then, he has continued to conduct and lead translational dermatology research as an independent fellow.

Register Now!

You May Also Like

Oral Tetracyclines and Acne: A Systematic Review for Dermatologists

| Acne, Featured Articles, The Latest | No Comments
Oral tetracyclines are the most widely prescribed systemic antibiotic for acne. Synthesis of efficacy and safety of traditional and novel oral tetracyclines is highly informative to clinical practice. The authors…

Sign Up To Attend Free ODAC Virtual Workshops

| Events | No Comments
Sign up now to attend Free ODAC Virtual 2021 Workshops Sign up now to attend Free ODAC Virtual 2021 Workshops The virtual ODAC conference, taking place January 14 – 17,…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Free Webinar: Restoring Skin Barrier Function: Why Formulation Matters

By COVID-19 Webinars, JDD Webinars, Skin Barrier Function No Comments

JDD Multimedia

Webinar Premiere

  • Thursday, July 23rd 2020
  • 12:00 pm EST

Space is limited – secure your spot today!

Register Now!

“Restoring Skin Barrier Function: Why Formulation Matters"

Join the JDD & CeraVe for an Exclusive Premiere Event

With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin.

Tune in as Professor Michael J. Cork BSC MB PhD FRCP and Professor Simon G. Danby discuss the skin-barrier restoring effect of a cream containing ceramides in a multi-vesicular emulsion for people with eczema-prone skin, as well as other skin conditions that require skin-barrier restoration.

Space is limited – secure your spot today!

Register Now!

Faculty


Professor Michael J. Cork

BSC MB PhD FRCP

Joined the University of Sheffield in 1991 as a lecturer in dermatology whilst continuing as a practising dermatologist for the NHS in Sheffield. Previously, a Registrar in Dermatology at the Royal Hallamshire Hospital, Sheffield, and a Registrar in Respiratory General Medicine at Leeds General Infirmary.

Professor Cork has been closely involved with research in many areas of dermatology; including Atopic Eczema(dermatitis), Psoriasis, Vitiligo and the Genetics of Skin Disease. Major current research work is aimed at identifying gene–environment interactions in the development of atopic dermatitis leading to skin barrier breakdown and the understanding of how topical agents interact with the skin barrier; using this information to enhance the treatment of atopic dermatitis.

Currently the Head of Sheffield Dermatology Research in the Department of Infection, Immunity & Cardiovascular Disease at the University of Sheffield Medical School and Honorary Consultant Dermatologist to both Sheffield Children´s Hospital NHS Foundation Trust and to Sheffield Teaching Hospitals NHS Foundation Trust.

 


Professor Simon G. Danby
PhD, BSC

Originally trained in biochemistry and molecular biology, Professor Danby  joined the University of Sheffield in 2005 as a post-doctoral scientist in the Academic Unit of Biomedical Genetics.

In this position, he worked exclusively for York Pharma on the early stage development of novel therapeutics and diagnostics for atopic dermatitis, psoriasis and malignant melanoma.

In 2009, he joined the Academic Unit of Dermatology Research as a post-doctoral Research Associate. The focus of his research in this role was improving our understanding of the structure and function of the epidermal (skin) barrier and its role in the development of disorders such as atopic dermatitis (AD).

At the beginning of 2012, Professor Danby  was awarded a 3-year unencumbered research fellowship from Johnson & Johnson to continue my research on the skin barrier and set up a dedicated research facility for conducting human skin research.

Since then, he has continued to conduct and lead translational dermatology research as an independent fellow.

Register Now!

You May Also Like

Oral Tetracyclines and Acne: A Systematic Review for Dermatologists

| Acne, Featured Articles, The Latest | No Comments
Oral tetracyclines are the most widely prescribed systemic antibiotic for acne. Synthesis of efficacy and safety of traditional and novel oral tetracyclines is highly informative to clinical practice. The authors…

Sign Up To Attend Free ODAC Virtual Workshops

| Events | No Comments
Sign up now to attend Free ODAC Virtual 2021 Workshops Sign up now to attend Free ODAC Virtual 2021 Workshops The virtual ODAC conference, taking place January 14 – 17,…

Insights On the Pediatric, Adolescent & Adult AD Patient

| Atopic Dermatitis, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

On Demand: Proper Hand & Face Care During COVID: What You and Your Patient Need to Know!

By COVID-19 Webinars, Global Health No Comments

JDD Multimedia

Webinars On Demand

Proper Hand & Face Care During COVID- What You and Your Patient Need to Know!

View on Demand Now

Tune in to hear from Drs. Adam Friedman, MD, FAAD, and Jonathan Silverberg, PhD, MPH as they discuss proper hand hygiene routines, how to counter act skin damage, importance of ceramides to repair the skin barrier and more.

Please Note: Due to technical difficulties with our webinar platform, this webinar ends at 34:36 after the final Q&A question.

Discussion Topics

  • Skin structure as related to hand/face care
  • The science/chemistry
  • How to counteract the skin damage
  • Gentle cleansing (pH/soap-free)
  • Importance of ceramides to repair skin barrier
  • Proper hand hygiene routine
  • Relevant face mask skincare rescue
  • and more!

Faculty

  • Adam Friedman, MD, FAAD
    Professor and Interim Chair of Dermatology
    Department of Dermatology
    George Washington School of Medicine and Health Sciences
  • Jonathan Silverberg, MD, PhD, MPH
    Associate Professor of Dermatology
    Department of Dermatology
    George Washington School of Medicine and Health Sciences

Sponsored By

View Now

You May Also Like

AcneFeatured ArticlesThe Latest
January 19, 2021

Oral Tetracyclines and Acne: A Systematic Review for Dermatologists

Oral tetracyclines are the most widely prescribed systemic antibiotic for acne. Synthesis of efficacy and safety of traditional and novel oral tetracyclines is highly informative to clinical practice. The authors…
Events
January 13, 2021

Sign Up To Attend Free ODAC Virtual Workshops

Sign up now to attend Free ODAC Virtual 2021 Workshops Sign up now to attend Free ODAC Virtual 2021 Workshops The virtual ODAC conference, taking place January 14 – 17,…
Atopic DermatitisPodcast Highlights
January 11, 2021

Insights On the Pediatric, Adolescent & Adult AD Patient

iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

By COVID-19 Webinars No Comments

JDD Multimedia

Webinar Premiere

  • Wednesday, May 13th 2020
  • 7:00 – 7:45 PM EST
View Now

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.

Moderators

  • Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)

Panelists

  • Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
  • Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
  • Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)

Space is limited; register today!

View Now

You May Also Like

AcneFeatured ArticlesThe Latest
January 19, 2021

Oral Tetracyclines and Acne: A Systematic Review for Dermatologists

Oral tetracyclines are the most widely prescribed systemic antibiotic for acne. Synthesis of efficacy and safety of traditional and novel oral tetracyclines is highly informative to clinical practice. The authors…
Events
January 13, 2021

Sign Up To Attend Free ODAC Virtual Workshops

Sign up now to attend Free ODAC Virtual 2021 Workshops Sign up now to attend Free ODAC Virtual 2021 Workshops The virtual ODAC conference, taking place January 14 – 17,…
Atopic DermatitisPodcast Highlights
January 11, 2021

Insights On the Pediatric, Adolescent & Adult AD Patient

iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Proper Hand & Face Care During COVID: What You and Your Patient Need to Know!

By COVID-19 Webinars, Global Health No Comments

JDD Multimedia

Webinar Premiere

  • Thursday, May 7th 2020
  • 1:00 PM – 1:30 PM EST

Healthcare providers who attend the entire webinar will receive products courtesy of CeraVe!

Register Now!

Proper Hand & Face Care During COVID- What You and Your Patient Need to Know!

Join the JDD & CeraVe for a #SkinChat!

Tune in to hear from Drs. Adam Friedman, MD, FAAD, and Jonathan Silverberg, PhD, MPH as they discuss proper hand hygiene routines, how to counter act skin damage, importance of ceramides to repair the skin barrier and more.

Discussion Topics

  • Skin structure as related to hand/face care
  • The science/chemistry
  • How to counteract the skin damage
  • Gentle cleansing (pH/soap-free)
  • Importance of ceramides to repair skin barrier
  • Proper hand hygiene routine
  • Relevant face mask skincare rescue
  • and more!

Product Giveaway

Healthcare providers who attend the entire webinar will receive the following products:

  • CeraVe Moisturizing Lotion (8 fl oz.)
  • CeraVe Moisturizing Cream (6 fl oz.)
  • CeraVe Hydrating Cleanser (8 fl oz.)

Space is limited; register today!

Register Now!

You May Also Like

AcneFeatured ArticlesThe Latest
January 19, 2021

Oral Tetracyclines and Acne: A Systematic Review for Dermatologists

Oral tetracyclines are the most widely prescribed systemic antibiotic for acne. Synthesis of efficacy and safety of traditional and novel oral tetracyclines is highly informative to clinical practice. The authors…
Events
January 13, 2021

Sign Up To Attend Free ODAC Virtual Workshops

Sign up now to attend Free ODAC Virtual 2021 Workshops Sign up now to attend Free ODAC Virtual 2021 Workshops The virtual ODAC conference, taking place January 14 – 17,…
Atopic DermatitisPodcast Highlights
January 11, 2021

Insights On the Pediatric, Adolescent & Adult AD Patient

iTunes Google Play Stitcher TuneIn Dr. Peter Lio, Dr. Lindsay Finklea & Dr. Adam Friedman   You can't truly understand someone until you walk a mile in their shoes. This…

Introducing the 2019 JDD Welcome Kit

By JDD Highlights
Introducing the 2019 JDD Welcome Kit!

Each year, the JDD not only reaches a record number of dermatology healthcare providers, but also the brightest and best dermatology residents, graduates, and interns from around the nation.

Our JDD Welcome Kit is an exclusive opportunity for sponsors to reach and support this next generation of thought leaders and patient advocates in dermatology by introducing the latest products, trends, and innovative  drug therapies.

We would like to offer a special thanks to this year’s Welcome Kit Sponsors:

Questions?
Contact the JDD today to learn more about reaching the next generation of Dermatology healthcare providers.  sales@sanovaworks.com

You May Also Like

Derm Community
June 16, 2020

A Must-Read: The Business of Dermatology

Edited by Drs. Jeffrey S. Dover and Kavita Mariwalla, and authored by impressive experts in the field, The Business of Dermatology offers a comprehensive guide to opening, maintaining, and sustaining…
Derm CommunityODACPhotoprotectionSkin Cancer
June 1, 2020

Controversies in Photoprotection

Adam Friedman, MD, FAAD is Professor and Interim Chair of Dermatology and serves as Residency Program Director, Director of Translational Research, and Director of the Supportive OncodermatologyProgram in the Department…
Derm CommunityODACSkin Cancer
May 18, 2020

Does This Skin Cancer Really Need Mohs?

The discussion was led by Dr. Vishal Patel and Dr. Sailesh Konda, and was moderated by Dr. William Hanke. In recognition of National Skin Cancer Month, the Journal of Drugs…